Published June 2, 2006
by Springer .
Written in English
|Contributions||Elke Bogner (Editor), Andreas Holzenburg (Editor)|
|The Physical Object|
|Number of Pages||538|
These strategies include new drugs and targets, novel modes of action, vector-based treatments and even the block of defined genes by inhibiting mRNA formation (siRNA). Highlights of this book include the discussion of: novel, promising compounds - concepts of therapy for new/emerging viruses - managing drug resistance - new therapeutic strategiesBrand: Elke Bogner; Andreas Holzenburg. Highlights of this book include the discussion of: novel, promising compounds - concepts of therapy for new/emerging viruses - managing drug resistance - new therapeutic strategies. This book presents an overview of the most recent developments. Concepts of therapy for DNA viruses: Selective inhibitors of the replication of poxviruses / Johan Neyts and Erik de Clercq --Maribavir: a promising new antiherpes therapeutic agent / Karen K. Biron --Benzimidazole-D-ribonucleosides as antiviral agents that target HCMV terminase / John C. Drach, Leroy B. Townsend and Elke Bogner --Recent developments in anti-herpesviral therapy based on protein . New Concepts of Antiviral Therapy by Andreas Holzenburg English | PDF | | Pages | ISBN: | MB Antiviral drugs are important tools for treatment or prevention of viral infections. These drugs were first used for monotherapy, but nowadays combinations of antiviral agents are often part of a standard treatment as evidenced by e.g. HAART (highly active antiretroviral therapy).
New Concepts of Antiviral Therapy Elke Bogner, Andreas Holzenburg Antiviral drugs are important tools for treatment or prevention of viral infections. These drugs were first used for monotherapy, but nowadays combinations of antiviral agents are often part of a standard treatment as. E. Bogner and A. Holzenburg (eds.), New Concepts of Antiviral Therapy, Abstract: Human immunodeficiency virus type 1 (HIV-1) was identified as causative agent of the acquired immune. Cite this chapter as: Ensser A. () Vector-based antiviral therapy. In: Holzenburg A., Bogner E. (eds) New Concepts of Antiviral : Armin Ensser. Once a virus infection is established, antiviral therapy is the option for the control of the viral infection. In principle, all the steps in the virus life cycle ranging from entry to release can be explored as molecular targets for antiviral therapy. In fact, the vast majority of antiviral drugs developed since the s are anti-HIV drugs.
Concepts of therapy for RNA viruses --Therapeutic vaccination in chronic hepadnavirus infection --Characterization of targets for antiviral therapy of Flaviviridae infections --Inhibition of Hepatitis C virus by nucleic acid-based antiviral approaches --Inhibitors of respiratory viruses --Anti-viral approaches against influenza viruses --A new approach to an Influenza virus live vaccine: Modification of eleavage site of the haemagglu reverse genetics --New concepts . Interesting concept, at minimum, though how they would get it deeper into the lungs is another question. Let’s not forget, radiation therapy — using X-Rays — is still used to destroy cancer. I guess, another use- it- early solution, if it works. END. U/D, PS: I found a Fox News mention. Drugs capable of inhibiting viruses in vitro were described in the s, but real progress was not made until the s, when agents capable of inhibiting virus-specific enzymes were first identified. The last decade has seen rapid progress in both our understanding of antiviral therapy and the number of antiviral agents on the market. Amantadine and ribavirin are available for treatment of Cited by: Antivirals are a class of medications that are used to treat viral infections. Most viral infections resolve spontaneously in immunocompetent individuals. The aim of antiviral therapy is to minimize symptoms and infectivity as well as to shorten the duration of illness. These drugs act by arresting the viral replication cycle at various stages.